Navigation Links
Aspirin, Statins May Reduce Problems After Heart Surgery
Date:10/19/2010

By Jenifer Goodwin
HealthDay Reporter

TUESDAY, Oct. 19 (HealthDay News) -- Patients who took aspirin before heart surgery suffered fewer heart attacks, stroke and other problems after their operations, and those given statins had better survival rates, two new studies find.

In the aspirin study, researchers identified 1,148 patients undergoing bypass, valve or other scheduled cardiac surgeries. Of those, 860 were taking aspirin in the five days before the surgery and 288 were not taking aspirin.

During the 30 days after surgery, nearly 13 percent of patients not taking aspirin experienced a heart attack, stroke or other major cardiac event, compared to only 8.6 percent in the aspirin group, the researchers found.

Aspirin also seemed to stave off post-surgery kidney failure, said senior study author Dr. Jian-Zhong Sun, an associate professor of anesthesiology at Thomas Jefferson University in Philadelphia.

About 3.8 percent of those taking aspirin experienced kidney failure after surgery, compared to 7 percent not taking aspirin.

"At this time, we still don't have a proven therapy to prevent the major complications involving the heart, brain and kidney that are common after cardiac surgery," Sun said. "Aspirin looks like a simple and promising drug to prevent some major complications."

Many Americans with cardiovascular disease take low-dose aspirin (81 milligrams/day). But the American Heart Association and the American College of Cardiology recommends patients stop taking aspirin before major surgery, including heart surgery, because aspirin can increase the risk of excessive bleeding and the need for blood transfusions, Sun pointed out.

More research needs to be done before he would recommend changing those guidelines, Sun added.

"If confirmed in other studies, particularly if we can proceed to a randomized clinical trial that shows aspirin does not increase the bleeding, then at that time we can make a recommendation to change the practice guidelines," Sun said.

In the study, patients taking aspirin did not have a higher rate of readmission due to infection, bleeding or fluid accumulation in the chest and around the heart, Sun reported.

The patients taking aspirin also tended to be older, and more likely to have hypertension, diabetes, peripheral artery disease and a history of coronary artery disease. Even though the aspirin group was on balance sicker than the non-aspirin group, they still did better, Sun noted.

"This corroborates other research that shows, as simple as it seems, aspirin is effective," said Dr. Vincent Bufalino, president and CEO of Midwest Heart Specialists outside Chicago.

In a second study, researchers in Finland found that patients who were not taking statins before undergoing coronary bypass surgery were twice as likely to die as people who were taking the cholesterol-lowering drugs.

Researchers identified 1,034 patients aged 42 to 81 undergoing bypass surgery. Of those, 703 were prescribed statins before surgery while 331 were not.

About 2.7 percent of patients given statins died in the month following surgery, compared to about 5.1 percent of those not given statins.

During the year after surgery, about 4 percent of those given statins died, compared to nearly 11 percent of those not taking statins, the researchers reported.

Statins are a widely prescribed class of drugs designed to lower cholesterol. For heart patients, cholesterol-lowering isn't necessarily the aim, Bufalino said. Research has shown statins can also reduce inflammation that can lead to blood clots, which can cause heart attacks and stroke.

It's common practice at U.S. hospitals for cardiac surgery patients to be prescribed statins before leaving the hospital, Bufalino said.

"There's been pretty convincing evidence that treating these people early and treating them regardless of their cholesterol level, whether it's high, medium or acceptable, is a good idea," Bufalino said. "This is just one more study providing solid evidence that putting these patients on statins clearly works."

The studies were to be presented Tuesday at the American Society of Anesthesiologists annual meeting in San Diego.

More information

The American Heart Association has more on statins, aspirin and other cardiac medications.

SOURCES: Jian-Zhong Sun, M.D., Ph.D., associate professor, anesthesiology, Thomas Jefferson University, Philadelphia; Vincent Bufalino, M.D., president/CEO, Midwest Heart Specialists, and clinical associate professor, medicine, Loyola University Stritch School of Medicine, Chicago; Oct. 19, 2010, presentations, American Society of Anesthesiologists annual meeting, San Diego


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Statins May Benefit Prostate Cancer Patients
2. Alternative to Statins Shows Promise
3. Statins may slow progression of multiple sclerosis, new study finds
4. Statins May Slow Progression of Multiple Sclerosis, New Study Finds
5. Do Statins Lower Male Sex Drive?
6. Statins Wont Lower Colon Cancer Risk
7. Statins decrease risk of clot-related diseases
8. Some statins have unintended effects and warrant closer monitoring, study finds
9. Too Many Stroke Patients Go Without Statins
10. MSU team studies connection between statins, tendon ruptures
11. Statins associated with lower cancer recurrence following prostatectomy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin, Statins May Reduce Problems After Heart Surgery
(Date:5/4/2016)... Providence, Rhode Island (PRWEB) , ... May 04, ... ... was launched in April 2016. SS&A teamed up with one of the top ... This legal information portal contains informative legal articles related to the law firm's ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of ... life forever with a same-day LASIK procedure at Christenbury Eye Center. The ... Jonathan Christenbury performed her surgery the same day as her in-office consultation and eye ...
(Date:5/4/2016)... ... May 04, 2016 , ... Advanced Spine & Sport Medical Rehabilitation Center, which ... is hosting a free seminar on stem cell injections. The seminar is scheduled for ... Sport, 4601 Telephone Road, Suite 110, Ventura, CA. There are only 10 seats available. ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... powerful cellular therapy software application that helps blood and marrow transplant (BMT) programs ... Transtem’s initial launch, Mediware has continued to enhance core application features. These enhancements ...
(Date:5/4/2016)... ... May 04, 2016 , ... International Conference on Obesity ... 25-27, 2016 at Las Vegas. It aims to bring together academicians, scientists, dietitians, ... research organizations across the globe; making the conference a perfect platform to share ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Ischemic Stroke ...  report to their offering.       ... Global Acute Ischemic Stroke Market and ... into Acute Ischemic Stroke pipeline products, Acute ...
Breaking Medicine Technology: